Cochlear stock forecast
Cochlear (OC5) Stock Forecast & Price Target
OC5 Analyst Ratings
OC5 Stock 12 Month Forecast
Average Price Target
CHF78.88▲(0.00% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Macquarie | CHF70.70 | hold | ― | Reiterated | 11/08/26 | ||
| David Low | UBS | CHF76.97 | hold | ― | Reiterated | 11/03/26 | ||
| Laura Sutcliffe | Citi | CHF79.82 | hold | ― | Reiterated | 10/19/26 | ||
| Unknown AnalystNot Ranked | Ord Minnett | CHF78.68 | hold | ― | Reiterated | 10/04/26 | ||
| David Bailey | Morgan Stanley | CHF75.83 | hold | ― | Reiterated | 10/01/26 | ||
| Craig Wong-Pan | RBC Capital | CHF66.71 | hold | ― | Reiterated | 09/15/26 | ||
| Derek Jellinek | Morgans | CHF78.92 | hold | ― | Reiterated | 08/20/26 | ||
| David Stanton | Jefferies | CHF73.21→CHF82.53 | hold | ― | Reiterated | 08/20/26 | ||
| Steven Wheen | Jarden | CHF94.07 | hold | ― | Reiterated | 08/19/26 | ||
| Chris Cooper | J.P. Morgan | CHF68.08→CHF84.61 | hold | ― | Reiterated | 08/19/26 | ||
| Shane Storey | Canaccord Genuity | CHF168.19→CHF68.42 | buy | ― | Reiterated | 04/29/26 | ||
| Unknown AnalystNot Ranked | Goldman Sachs | CHF139.63→CHF123.04 | hold | ― | Reiterated | 03/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Unknown AnalystMacquarieNot Ranked | HoldReiteratedCHF70.70 | 11/08/26 | ― | ||
| David LowUBS | HoldReiteratedCHF76.97 | 11/03/26 | ― | ||
| Laura SutcliffeCiti | HoldReiteratedCHF79.82 | 10/19/26 | ― | ||
| Unknown AnalystOrd MinnettNot Ranked | HoldReiteratedCHF78.68 | 10/04/26 | ― | ||
| David BaileyMorgan Stanley | HoldReiteratedCHF75.83 | 10/01/26 | ― | ||
| Craig Wong-PanRBC Capital | HoldReiteratedCHF66.71 | 09/15/26 | ― | ||
| Derek JellinekMorgans | HoldReiteratedCHF78.92 | 08/20/26 | ― | ||
| David StantonJefferies | HoldReiteratedCHF73.21→CHF82.53 | 08/20/26 | ― | ||
| Steven WheenJarden | HoldReiteratedCHF94.07 | 08/19/26 | ― | ||
| Chris CooperJ.P. Morgan | HoldReiteratedCHF68.08→CHF84.61 | 08/19/26 | ― | ||
| Shane StoreyCanaccord Genuity | BuyReiteratedCHF168.19→CHF68.42 | 04/29/26 | ― | ||
| Unknown AnalystGoldman SachsNot Ranked | HoldReiteratedCHF139.63→CHF123.04 | 03/13/26 | ― |
Best Analysts Covering Cochlear
Copying Shane Storey's trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of -3.96% per trade.
Copying Shane Storey's trades and holding each position for 1 Year would result in 22.22% of your transactions generating a profit, with an average return of -14.96% per trade.
Copying Shane Storey's trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -16.34% per trade.
OC5 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 10 | 20 | 22 | 22 | 13 |
| Sell | 1 | 1 | 1 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 11 | 21 | 23 | 22 | 13 |
In the current month, OC5 has received 0 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. OC5 average Analyst price target in the past 3 months is 78.88.
OC5 Financial Forecast
OC5 Earnings Forecast
Next quarter’s earnings estimate for OC5 is CHF 1.51 with a range of CHF 1.38 to CHF 1.87. The previous quarter’s EPS was CHF 1.14. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
OC5 Sales Forecast
Next quarter’s sales forecast for OC5 is CHF 694.92M with a range of CHF 672.48M to CHF 737.28M. The previous quarter’s sales results were CHF 676.40M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
